Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Zhao

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
BMJ Open|April 29, 2022
Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit-TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unitAndrew Bivard, Henry Zhao, Skye Coote, et al.
JAMA Neurology|February 7, 2022
Comparison of Mobile Stroke Unit With Usual Care for Acute Ischemic Stroke Management: A Systematic Review and Meta-analysisGuillaume Turc, Melika Hadziahmetovic, Silke Walter, et al.
Stroke|December 22, 2020
Utility of Severity-Based Prehospital Triage for Endovascular Thrombectomy: ACT-FAST Validation StudyHenry Zhao, Karen Smith, Stephen Bernard, et al.
NEJM Evidence|December 22, 2025
A Randomized Trial of Telemedicine Models of Care on a Mobile Stroke UnitVignan Yogendrakumar, Anna H Balabanski, Hannah Johns, et al.
Immunity|January 29, 2026
Scalable TCR synthesis and screening enable antigen reactivity mapping in vitiligoStephanie A Gaglione, Rachit S Mukkamala, Chirag Krishna, et al.
The Lancet. Neurology|May 7, 2022
Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trialAndrew Bivard, Henry Zhao, Leonid Churilov, et al.
Stroke|February 21, 2020
Melbourne Mobile Stroke Unit and Reperfusion Therapy: Greater Clinical Impact of Thrombectomy Than ThrombolysisHenry Zhao, Skye Coote, Damien Easton, et al.
Stroke and Vascular Neurology|December 1, 2021
Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase II randomised placebo-controlled double-blind multicentre trialNawaf Yassi, Henry Zhao, Leonid Churilov, et al.
The Lancet. Neurology|April 22, 2024
Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trialNawaf Yassi, Henry Zhao, Leonid Churilov, et al.
JAMA|February 21, 2020
Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke: The EXTEND-IA TNK Part 2 Randomized Clinical TrialBruce C V Campbell, Peter J Mitchell, Leonid Churilov, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
BMJ Open|April 29, 2022
Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit-TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unitAndrew Bivard, Henry Zhao, Skye Coote, et al.
JAMA Neurology|February 7, 2022
Comparison of Mobile Stroke Unit With Usual Care for Acute Ischemic Stroke Management: A Systematic Review and Meta-analysisGuillaume Turc, Melika Hadziahmetovic, Silke Walter, et al.
Stroke|December 22, 2020
Utility of Severity-Based Prehospital Triage for Endovascular Thrombectomy: ACT-FAST Validation StudyHenry Zhao, Karen Smith, Stephen Bernard, et al.
NEJM Evidence|December 22, 2025
A Randomized Trial of Telemedicine Models of Care on a Mobile Stroke UnitVignan Yogendrakumar, Anna H Balabanski, Hannah Johns, et al.
Immunity|January 29, 2026
Scalable TCR synthesis and screening enable antigen reactivity mapping in vitiligoStephanie A Gaglione, Rachit S Mukkamala, Chirag Krishna, et al.
The Lancet. Neurology|May 7, 2022
Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trialAndrew Bivard, Henry Zhao, Leonid Churilov, et al.
Stroke|February 21, 2020
Melbourne Mobile Stroke Unit and Reperfusion Therapy: Greater Clinical Impact of Thrombectomy Than ThrombolysisHenry Zhao, Skye Coote, Damien Easton, et al.
Stroke and Vascular Neurology|December 1, 2021
Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase II randomised placebo-controlled double-blind multicentre trialNawaf Yassi, Henry Zhao, Leonid Churilov, et al.
The Lancet. Neurology|April 22, 2024
Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trialNawaf Yassi, Henry Zhao, Leonid Churilov, et al.
JAMA|February 21, 2020
Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke: The EXTEND-IA TNK Part 2 Randomized Clinical TrialBruce C V Campbell, Peter J Mitchell, Leonid Churilov, et al.
Pageof 7